Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3280 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-07-17 | 2019-11-25 | 89557 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-18 | 2019-11-16 | 94203 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-11-20 | 2019-11-25 | 99320 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-22 | 2020-09-14 | 103926 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-29 | 2020-09-14 | 104700 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-05-08 | 2021-03-09 | 114327 |
| APO-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2022-07-29 | 2023-09-01 | 165727 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-09-01 | 2022-11-20 | 168353 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-09-01 | 2022-09-16 | 168356 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-09 | 2023-01-13 | 177618 |
| APO-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2022-12-16 | 2023-08-18 | 178766 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-04-21 | 2023-09-01 | 189999 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-05-12 | 2023-09-01 | 192361 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-06-09 | 2023-08-18 | 194581 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-06-23 | 2023-09-01 | 196306 |
| APO-VERAP SR | 240MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-10 | 2019-12-04 | 255 |
| APO-VERAP SR | 180MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-10 | 2019-12-04 | 260 |
| APO-VERAP SR | 120MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-11 | 2019-12-04 | 552 |
| APO-VORICONAZOLE | 200MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 252 |
| APO-VORICONAZOLE | 50MG | TABLET | Resolved | 2017-06-06 | 2017-08-15 | 12088 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |